Page last updated: 2024-12-07

3-methyluracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3-Methyluracil (3-MU) is a naturally occurring pyrimidine base. It can be found in DNA and RNA as a result of methylation of uracil, and plays a role in the regulation of gene expression. 3-MU has also been found to have anti-tumor and anti-inflammatory effects. Its synthesis can be achieved through various methods, including the methylation of uracil using methyl iodide in the presence of a base, or by enzymatic methylation. 3-MU is studied for its potential therapeutic applications, such as its use in the treatment of cancer and inflammatory diseases. The compound has also been investigated for its ability to inhibit the growth of viruses and bacteria.'

3-methyluracil : A pyrimidone that is uracil with a methyl group at position 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID79066
CHEBI ID74732
SCHEMBL ID40761
SCHEMBL ID13242249
MeSH IDM0157295

Synonyms (41)

Synonym
3-methyl-2,4(1h,3h)-pyrimidinedione
nsc 45626
2,4-dihydroxy-3-methylpyrimidine
nsc-45626
608-34-4
2,3h)-pyrimidinedione, 3-methyl-
nsc45626
AC-907/25014072
3-methyluracil
3-methyl-1h-pyrimidine-2,4-dione
3-methylpyrimidine-2,4(1h,3h)-dione
inchi=1/c5h6n2o2/c1-7-4(8)2-3-6-5(7)9/h2-3h,1h3,(h,6,9
2,4(1h,3h)-pyrimidinedione, 3-methyl-
uracil, methyl-
methyl-2,4(1h,3h)-pyrimidinedione
2,4(1h,3h)-pyrimidinedione, methyl-
AKOS003348643
FT-0692244
AKOS002304012
27942-00-3
CHEBI:74732
3-meu
SCHEMBL40761
3-methylpyrimidine-2,4(1h, 3h)-dione
VPLZGVOSFFCKFC-UHFFFAOYSA-N
SCHEMBL13242249
W-203272
Z2588063529
mfcd00038014
A868880
2-hydroxy-3-methylpyrimidin-4(3h)-one
2-hydroxy-3-methyl-4-oxo-3,4-dihydropyrimidine
AS-47233
Q15632765
DTXSID30878779
SB57470
SY046017
F12763
CS-0199452
EN300-297986
3-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
pyrimidoneA pyrimidine carrying one or more oxo substituents.
nucleobase analogueA molecule that can substitute for a normal nucleobase in nucleic acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (18.18)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's3 (27.27)24.3611
2020's1 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.17

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.17 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index30.82 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.17)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]